PRECISE-CTCA Trial
Start date:4th December Co-ordinated by:
Rachel O'Brien Main trial site:
RIE
This is a single-centre observational study. All participants will be recruited from the Emergency Department at the Royal Infirmary of Edinburgh and invited for an outpatient CTCA at the Clinical Research Imaging Centre. This study will inform Dr. Lee’s PhD funded as part of a British heart Foundation Fellowship.
Local PI
Dr Ken Lee
Cardiology Research Fellow
Research Team
Rachel O'Brien
Lead Research Nurse
Polly Black
Senior Research Nurse
Julia Grahamslaw
Lead Research Nurse
Clare Moceivei
Research Nurse- Bank Staff
Alison Williams
Senior Research Nurse
Fiona McCurrach
Senior Research Nurse
Caroline Blackstock
AMU Senior Research Nurse
Alison Grant
Senior Research Nurse
Lisa Donald
Research Nurse
Claire Cheyne
Senior Research Nurse
More EMERGE Trials
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.
PRECISE-CTCA Trial
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.